Viewing Study NCT06012734


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2025-12-27 @ 10:48 PM
Study NCT ID: NCT06012734
Status: RECRUITING
Last Update Posted: 2024-08-30
First Post: 2023-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module